Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PROSTATE CANCER, SUSCEPTIBILITY TO
|
6 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.700 | 0 | ||||||||
Cleft lip or lips
|
37 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||
Cleft upper lip
|
282 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||
Colorectal Carcinoma
|
1962 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.020 | 1.000 | 2 | 2005 | 2019 | |||||
Neoplasms
|
1644 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.020 | 1.000 | 2 | 2012 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.020 | 1.000 | 2 | 2005 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Cleft Palate
|
158 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Cleft palate, isolated
|
70 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Kidney Calculi
|
71 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant neoplasm of breast
|
3417 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant neoplasm of stomach
|
615 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Nephrolithiasis
|
99 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Primary malignant neoplasm
|
1374 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Stomach Carcinoma
|
652 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Uranostaphyloschisis
|
75 | 0.716 | 0.440 | 16 | 68737131 | upstream gene variant | C/A | snv | 0.24 | 0.010 | 1.000 | 1 | 2011 | 2011 |